Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series

INTRODUCTION: Tedizolid phosphate 200 mg, once daily for 6 days, has recently been approved for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSIs) in several countries; however, clinical experience in real-life settings is currently limited. Here, we report o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shlyapnikov, Sergey, Jauregui, Arturo, Khachatryan, Nana N., Kurup, Asok, de la Cabada-Bauche, Javier, Leong, Hoe N., Li, Li, Wilcox, Mark H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098749/
https://www.ncbi.nlm.nih.gov/pubmed/30003513
http://dx.doi.org/10.1007/s40121-018-0207-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098749/
https://www.ncbi.nlm.nih.gov/pubmed/30003513
http://dx.doi.org/10.1007/s40121-018-0207-0

Ejemplares similares